Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Schiller
VIEWORKS

Optical Coherence Tomography Shown to Predict Tumor Margins Effectively

By Medimaging International staff writers
Posted on 28 Jan 2013
Image: The VivoSight optical coherence tomography (OCT) scanner (Photo courtesy of Michelson Diagnostics).
Image: The VivoSight optical coherence tomography (OCT) scanner (Photo courtesy of Michelson Diagnostics).
A precise determination of tumor margins is vital for the effective treatment of skin cancer patients. This is particularly true for patients undergoing Mohs micrographic surgery, where complete tumor removal may require repeated invasive procedures.

Recent studies conducted in two US Healthcare facilities used the VivoSight optical coherence tomography (OCT) scanner, manufactured by Michelson Diagnostics, Ltd. (South London, UK), to prospectively improve clinically estimated tumor margins prior to Mohs micrographic surgery.

The first, a 52-patient study, conducted by Prof. Dan Seigel, from the department of dermatology, State University of New York Downstate Medical Center (Brooklyn, NY, USA), concluded that “OCT assessment has the potential to reduce the excised area without compromising the integrity of tumor-free borders.” The study’s findings were published January 2013 in the journal Dermatologic Surgery.

Another case study of a patient with very ill defined margins concluded that, “High-resolution imaging with a multibeam OCT device can accurately predict tumor margins of a BCC prior to Mohs micrographic surgery […] with any tumor, particularly ill-defined ones, the use of OCT could potentially reduce the number of stages required to clear the tumor leading to shorter operative times and reduction of cost.”

The findings were published December 2012 in the journal Case Reports in Dermatology by researchers from the Permanente Medical Group (Elk Grove, CA, USA) and SkinCare Physicians (Chestnut Hill, MA, USA).

Dr. Gertraud Kraehn-Senftleben, a dermatologists from Blaubeuren, Germany, and a member of the German Onkoderm Network, and one of the first clinicians to use the VivoSight OCT scanner in routine clinical practice, commented, “These studies reflect the day to day experience in our clinic. We routinely scan tumor margins prior to micrographic surgery and our experience of more than 150 patients is that it reduces the amount of repeat surgery required. This is a great benefit for both the patient and the dermatologist.”

Related Links:
Michelson Diagnostics
State University of New York Downstate Medical Center
SkinCare Physicians



Channels

Radiography

view channel
Image: Siemens MAMMOMAT FFDM System (Photo courtesy of Siemens Healthcare).

New FFDM Systems Transform Mammography Services Across Northern Ireland

The Northern Ireland Breast Screening Program has been equipped with 14 new mobile and static Full Field Digital Mammography (FFDM) systems. The new systems will replace existing analog ones and enable... Read more

MRI

view channel

Study Uses MRI to Determine the Progression of Cerebral Malaria in Malawi

Researchers have used Magnetic Resonance Imaging (MRI) to find the pathogenetic processes and causes of death in children suffering from Cerebral Malaria in Malawi. MRI scans only became available in Malawi in the year 2009. Between 15%–25% of children in Africa suffering from cerebral malaria, which causes brain swelling,... Read more

Ultrasound

view channel
Image: Portable Ultrasound in Use (Photo courtesy of SonoSite).

Portable Diagnostic Ultrasound System Deployed on Soccer Field

A new hand-held point-of-care diagnostic ultrasound system has been deployed by a top soccer club. The ultrasound system was used to speed up injury diagnosis on the football field, and to reassure... Read more

Nuclear medicine

view channel
Image: PET scan images (Courtesy of King’s College London).

Preventing Unnecessary Radiotherapy for Patients with Early-Stage Hodgkin’s Lymphoma

A new study suggested that patients with early-stage (stage 1a or 2a) Hodgkin’s lymphoma disease, who underwent three cycles of chemotherapy with the drugs doxorubicin, bleomycin, vinblastine, and dacarbazine... Read more

Industry News

view channel

New Analysis Forecasts Strong Growth for Advanced Diagnostic Imaging Services in Singapore

A new market analysis shows that revenues for the private outpatient diagnostic imaging services market in Singapore are forecast to grow from USD 127.8 million in 2013 to an estimated USD 273 million in 2019. Private practitioners in Singapore provide 80% of the primary healthcare services, while the remaining 20% are... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.